Roche Holding Ag Stock Gross Profit
RHHBF Stock | USD 254.50 8.50 3.23% |
Roche Holding AG fundamentals help investors to digest information that contributes to Roche Holding's financial success or failures. It also enables traders to predict the movement of Roche OTC Stock. The fundamental analysis module provides a way to measure Roche Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roche Holding otc stock.
Roche |
Roche Holding AG OTC Stock Gross Profit Analysis
Roche Holding's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Roche Holding Gross Profit | 47.83 B |
Most of Roche Holding's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roche Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, Roche Holding AG reported 47.83 B of gross profit. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The gross profit for all United States stocks is 74.7% lower than that of the firm.
Roche Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roche Holding's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Roche Holding could also be used in its relative valuation, which is a method of valuing Roche Holding by comparing valuation metrics of similar companies.Roche Holding is currently under evaluation in gross profit category among related companies.
Roche Fundamentals
Return On Equity | 0.45 | |||
Return On Asset | 0.15 | |||
Profit Margin | 0.19 % | |||
Operating Margin | 0.32 % | |||
Current Valuation | 287.91 B | |||
Shares Outstanding | 106.69 M | |||
Shares Owned By Insiders | 75.31 % | |||
Shares Owned By Institutions | 8.56 % | |||
Price To Earning | 21.63 X | |||
Price To Book | 11.61 X | |||
Price To Sales | 4.11 X | |||
Revenue | 62.8 B | |||
Gross Profit | 47.83 B | |||
EBITDA | 22.26 B | |||
Net Income | 13.93 B | |||
Cash And Equivalents | 6.81 B | |||
Cash Per Share | 8.50 X | |||
Total Debt | 16.08 B | |||
Debt To Equity | 1.00 % | |||
Current Ratio | 1.11 X | |||
Book Value Per Share | 35.03 X | |||
Cash Flow From Operations | 20.98 B | |||
Earnings Per Share | 19.18 X | |||
Price To Earnings To Growth | 4.18 X | |||
Target Price | 423.65 | |||
Number Of Employees | 103.61 K | |||
Beta | 0.19 | |||
Market Capitalization | 246.23 B | |||
Total Asset | 92.32 B | |||
Retained Earnings | 25.51 B | |||
Working Capital | 2.16 B | |||
Current Asset | 26.61 B | |||
Current Liabilities | 24.46 B | |||
Z Score | 9.0 | |||
Annual Yield | 0.03 % | |||
Five Year Return | 3.23 % | |||
Net Asset | 92.32 B | |||
Last Dividend Paid | 9.5 |
About Roche Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roche Holding AG. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Roche Holding AG information on this page should be used as a complementary analysis to other Roche Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Roche OTC Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |